Evidence map›Paper›PMID 42077677›Full record

ArticleCureus2026

Buschke-Löwenstein Tumor of the Vulva: Clinical Neglect, Molecular Continuum, and Pathogenetic Insights.

Jesús Iván Martínez-Ortega, Frida Itzel Rosas-Lezama, Arely Gissell Ramirez Cibrian

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jesús Iván Martínez-OrtegaHistology, Autonomous University of Nuevo Leon, Monterrey, MEX.
Frida Itzel Rosas-LezamaInternal Medicine, General Zone Hospital, Mexican Institute of Social Security, Merida, MEX.
Arely Gissell Ramirez CibrianGeneral Medicine, Universidad Autónoma de Campeche, Campeche, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Buschke-Löwenstein tumor (BLT), also known as giant condyloma acuminatum, is an uncommon manifestation of low-risk human papillomavirus (HPV) infection, characterized by massive exophytic growth and substantial local morbidity. Although histologically low-grade, BLT can become profoundly function-limiting and carries a variable risk of malignant transformation, particularly in long-standing or untreated lesions. We report a case of a neglected giant vulvar BLT in an adult woman who presented after several years of progressive growth, resulting in impaired ambulation, hygiene difficulties, and sexual dysfunction. Surgical excision with margin control was performed, leading to functional improvement, and histopathological examination confirmed BLT, without evidence of invasive squamous cell carcinoma (SCC). This case highlights the clinical consequences of delayed diagnosis and limited access to care, positioning BLT as a paradigmatic clinically neglected disease. Emerging pathogenetic evidence supports the concept that BLT represents an extreme along a continuous spectrum of low-risk HPV-associated disease, in which sustained epithelial hyperplasia, stochastic persistence of infected basal cell clones, and local immune modulation permit progressive, space-occupying growth over time. Early recognition and definitive surgical management remain essential to prevent severe morbidity and reduce the risk of recurrence or malignant progression.

Indexed as

benign vulvar tumorsbuschke-löwenstein tumorepithelial hyperplasiaexophytic tumorsgiant condyloma acuminatumhuman papillomavirus (hpv)low-risk human papillomavirus (lr-hpv)neglected diseasesurgical managementvulvar disease

Identifiers

PMID42077677
PMCPMC13130267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.